Cephalon Inc announced that Victor F.C. Raczkowski has joined the company as Vice President, Worldwide Regulatory Affairs, with responsibility for all regulatory aspects of drug development.

Dr. Raczkowski comes to Cephalon from the U.S. Food and Drug Administration (FDA) where he served most recently as Director of the Office of Drug Safety within the Administration's Center for Drug Evaluation and Research (CDER). Prior to that, he held several Director and Deputy Director positions in CDER and in FDA's Center for Biologics Evaluation and Research. He began his career with the FDA in 1990.

"Victor's experience and expertise in the regulatory aspects of drug development is a great asset for Cephalon, and we are very pleased to have him as a part of our growing team," said Paul Blake, FRCP, Senior Vice President, Clinical Research and Regulatory Affairs.

Dr. Raczkowski has authored multiple papers related to the effects of various substances on the central nervous system, is a distinguished speaker, and has served as a spokesperson for the FDA on select drug issues. He received a bachelor's degree in chemistry from Swarthmore College, his Master's of Science degree in pharmacology from the University of Chicago, and his medical degree from Rush Medical College in Chicago. He is also board certified in pediatrics and pediatric cardiology.